Company page

Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc. (Ticker: LXRX) is a public company based in the United States, focusing on the development of innovative therapies for various diseases. With a market capitalization of approximately $892.8 million, Lexicon is actively engaged in advancing its pharmaceutical pipeline. The company aims to address unmet medical needs through its research and development efforts.